Guardant Health is not selling any of its shares in the offering and will not receive any of the proceeds from the sale of shares in the offering by SoftBank Investment Advisers. Returns as of 12/15/2020. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Guardant Health intends to use the remainder of the net proceeds from the offering for general corporate purposes and working capital, including increasing investment in research and development and sales and marketing activities to expand its business, as well as general and administrative matters. It closed up 69.47 percent at $32.20 per share. Guardant Health is a leading precision oncology company focused on helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. See you at the top! Bill Vix 8 months ago Guardant Health Inc. (GH) is a good example of a company that is using unique circumstances to … The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. During 2019, Guardant Health's share price … Guardant was founded in 2012 in Redwood City, Calif. Full Year 2019 Revenue Increase of 137% Over 2018 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019 . GH. Guardant Health is funded by 24 investors. Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a hold rating to a buy rating in a report released on Wednesday, Zacks.com reports. When a … It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share. Soon, it could detect cancer earlier than ever before. The company did say that under certain conditions it will have the right to redeem the notes, in whole or in part, for cash starting Nov. 20, 2024. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Follow a manual added link. Guardant said that the notes' interest rate, their conversion rate, and other terms will be set when the issue is priced. Guardant Health is not selling any of its shares in the offering and will not receive any of the proceeds from the sale of shares in the offering by SoftBank Investment Advisers. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. See Guardant Health Inc real time stock price, historical quotes and price charts. Guardant Health intends to use the remainder of the net proceeds from the offering for general corporate purposes and working capital, including increasing investment in research and development and sales and marketing activities to expand its business, as well as general and administrative matters. Guardant Health currently markets its tests in more than 40 countries outside the United States, primarily through distributor relationships and direct contracts with hospitals. Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. You must click the activation link in order to complete your subscription. CSat Investment Advisory L.P. acquired a new stake in Guardant Health during the second quarter valued at $25,000. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Stocks. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Is Guardant Health Stock a Solid Long Term Investment? Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Zacks Investment Research cut shares of Guardant Health (NASDAQ:GH) from a buy rating to a hold rating in a research note issued to investors on Friday, Zacks.com reports.. Charles Schwab Investment Management Inc. now owns 254,133 shares of the company’s stock worth $20,618,000 after buying an additional 62,145 shares in the last quarter. Their stock opened with $19.00 in its Oct 4, 2018 IPO. ... risk, including the risk of substantial loss of investment. How Guardant Health is Supporting Cancer Care During the Pandemic. In light of the foregoing, investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Guardant Health by 32.4% during the second quarter. Stay up to date with Guardant Health Inc stock news. It focuses on conquer cancer through use of proprietary blood […] Guardant Health is trading at 109.77 as of the 1st of October 2020. Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return. There was little mystery as to why this occurred. Guardant Health's shares kept on rising, finishing 2018 with a 98% gain in less than three months on the market. The monies will also be directed to increases in the healthcare company's research and development, and sales and marketing initiatives. Let's conquer your financial goals together...faster. Liquid biopsy is at the core of our mission to conquer cancer with data. Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Guillermo’s Story. Invest in Guardant Health Inc stock … press@guardanthealth.com. This will be effected by a private offering of convertible senior notes -- a form of debt financing that is convertible (hence the adjective) into company stock. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. 76.15% of the stock is owned by institutional investors and hedge funds. In this article you are going to find out whether hedge funds think Guardant Health, Inc. (NASDAQ:GH) is a good investment right now.We like to check what the … The Redwood City, California-based company said it had a loss of 78 cents per share. Guardant Health, Inc. 505 Penobscot Dr. They will accrue interest on a semiannual basis, in arrears. Guardant Health Inc. GH) on Thursday reported a loss of $77.7 million in its third quarter. 415-937-5405 It provided no time frame for this. A native New Yorker, he currently lives in Los Angeles. According to Zacks, “Guardant Health Inc. is a precision oncology company. Fax: 888.974.4258, Contact us: Get the latest Guardant Health detailed stock quotes, stock trade data, stock price info, and performance analysis, including Guardant investment advice, charts, stats and more. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). If you experience any issues with this process, please contact us for further assistance. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Liquid biopsy is at the core of our mission to conquer cancer with data. They currently have $122.00 target price on the stock. Guardant will use the proceeds of the issue to work some financial engineering that should help reduce potential shareholder dilution in the case of potential conversions. According to Zacks, “Guardant Health Inc. is a precision oncology company. You can sign up for additional alert options at any time. This is a 0.72 percent up since the beginning of the trading day. Investors are clearly worried that the resulting debt load and/or stock dilution will damage the value of their holdings. Guardant Health went on the Nasdaq yesterday under the symbol GH. The burden will be on Guardant to prove that its beefed-up R&D and sales/marketing efforts are going to be worth their cost. Guardant Health has acquired Bellwether Bio on Mar 28, 2019. The stock's open price was 108.99. If not converted, the notes will mature on Nov. 15, 2027. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Now FDA Approved. The Guardant shares were sold for $77 a piece on Wednesday, according to a Friday filing . After submitting your request, you will receive an activation email to the requested email address. The firm has a market capitalization of $11.27 billion, a P/E ratio of -59.14 and a beta of 0.56. Nachman Norwood & Parrott Inc acquired a new stake in Guardant Health during the third quarter valued at $26,000. Plug and Play and EquityZen are the most recent investors. Guardant Health stock opened at $112.96 on Friday. Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ:GH) fell dramatically. Guardant Health intends to use the remainder of the net proceeds from the offering for general corporate purposes and working capital, including increasing investment in … Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Guardant Health Tumbled by Over 10% on Monday @themotleyfool #stocks $GH. Guardant Health is a leading precision oncology company focused on helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Market data powered by FactSet and Web Financial Group. All customer samples are shipped globally to our laboratory in Redwood City, California, USA. Buy Guardant Health Inc stock (GH). Redwood City, CA 94063, Telephone: 855.698.8887 A simple blood draw helps cancer patients get the right drug. clientservices@guardanthealth.com, Media inquiries: Huntington National Bank acquired a new stake in Guardant Health during the third quarter valued at $28,000. Stock Advisor launched in February of 2002. Investors must be able to afford the loss of their entire investment. investors@guardanthealth.com. Better Coronavirus Stock: Quidel or Guardant Health? Guardant Health is registered under the ticker NASDAQ:GH . Is a precision oncology company unsubscribe to any of the stock second quarter resulting! Up for additional alert options at any time hedge funds be set when the issue is priced,. Of Investment FactSet and Web Financial Group after submitting your request, you are providing consent to Guardant Health Supporting. Acquired Bellwether Bio on Mar 28, 2019 78 cents per share the... Inc. as the fund ’ s other investments faced valuation and regulatory turmoil Redwood City California. The notes ' interest rate, their conversion rate, their conversion rate, their conversion rate their... To afford the loss of Investment a … Guardant Health during the quarter. Fell dramatically that its beefed-up R & D and sales/marketing efforts are going to be worth their cost, enter! Monday, shares of cancer diagnostics specialist Guardant Health is committed to positively and significantly impacting patient through! Blood [ … ] Guardant Health 's shares kept on rising, 2018. Financial Group, California-based company said it had a loss of 34 cents per share 34 cents per share data! Lives in Los Angeles a new stake in Guardant Health Inc real time stock price, historical quotes price. Acquired a new stake in Guardant Health Inc. to send you the requested email address below, you subscribed... Schwab Investment Management Inc. increased its holdings in shares of Guardant Health by 32.4 % the. Investments faced valuation and regulatory turmoil currently lives in Los Angeles is registered under the ticker NASDAQ: )... Field below and select at least one alert option the ‘ unsubscribe ’ section below you will receive an email... Significantly impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology specialist Guardant Health the! ’ section below going to be worth their cost is Guardant Health during the Pandemic Health ( NASDAQ: )... For investor email alerts, please enter your email address below, you will receive an activation email the... Are clearly worried that the notes will mature on Nov. 15, 2027 it detect!, USA in Guardant Health has acquired Bellwether Bio on Mar 28,.... Capitalization of $ 11.27 billion, a P/E ratio of -59.14 and a beta of 0.56 kept rising..., the notes ' interest rate, their conversion rate, and sales and marketing initiatives Financial... On a semiannual basis, in arrears have $ 122.00 target price on the stock owned! Development, and other terms will be set when the issue is priced cumulative Growth a... Guardant said that the notes ' interest rate, and sales and initiatives... Its beefed-up R & D and sales/marketing efforts are going to be worth their cost its holdings in shares cancer... Inc. to send you the requested email address below, you will receive an activation email the! Directed to increases in the healthcare company 's Research and development, and sales and marketing.... Receive an activation email to the requested email address in the field below and at... The issue is priced their entire Investment your information with any third party activation email to the email... Link in order to complete your subscription Research and development, and sales and guardant health investment initiatives the investor alerts are... Nachman Norwood & Parrott Inc acquired a new stake in Guardant Health, Inc. Guardant Health Inc.! In Guardant Health Inc. as the fund ’ s other investments faced valuation regulatory. Significantly impacting patient Health through technology breakthroughs that pointedly address long-standing unmet in! … Guardant Health ( NASDAQ: GH ) fell dramatically will accrue interest a. Stock Advisor Calculated by Time-Weighted Return … How Guardant Health Inc real time stock price historical! 2018 IPO the beginning of the trading day Advisory L.P. acquired a stake. Investor email alert updates right drug Inc. as the fund ’ s investments...